Enables and supports patients’ timely access to medicines appropriate for their clinical needs

Descriptors

  • Identifies areas of unmet medical need and related evidence gaps.
  • Provides clinical input into product profiling and positioning.
  • Contributes to the development of Health Technology Assessments (HTAs).
  • Engages in pharmacoeconomic procedures associated with health technology commercialisation.
  • Keeps the welfare and interests of patients and clinical trial participants at the forefront of decision-making.
  • Provides effective procedures giving patients access to unlicensed medicines.
  • Participates in liaising with regulators regarding patient engagement in medicines development.
  • Participates in activities that influence the development lifecycle of medicines.
  • Identifies and engages with stakeholders in the provision of medicines; facilitates the collection of qualitative data and feedback on the safe and effective use of medicines.
  • Participates in generating strategic insights affecting the use of medicines.

Evidence to inform decision

  • Regulatory submissions/HTA submissions
  • Clinical research documentation
  • Documentation of area of unmet medical need
  • Patient engagement activities
  • Workplace-based assessments (WPBAs)
  • Core competencies
  • ES report
  • Course assessment
  • Diploma in Pharmaceutical Medicine (DPM)

Mapping to GPCs

Domain 1 – Professional values and behaviours

Domain 2 – Professional skills:

  • Practical skills
  • Communication and interpersonal skills
  • Dealing with complexity and uncertainty

Domain 3 – Professional knowledge:

  • Professional requirements
  • National legislative requirements
  • The health service and healthcare systems in the four countries

Domain 4 – Capabilities in health promotion and illness prevention

Domain 5 – Capabilities in leadership and team working

Domain 6 – Capabilities in patient safety and quality improvement:

  • Patient safety
  • Quality improvement

Domain 7 – Capabilities in safeguarding vulnerable groups

Domain 9 – Capabilities in research and scholarship